Advertisements



BioLineRx reports "positive" results from GENESIS Phase 3 trial of motixafortide

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 4th, 2021

Bristol-Myers reports "positive" results from Phase 3 CheckMate -648 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 8th, 2021

Ampio reports "preliminary positive results" in AP-014 Phase I trial of Ampion

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 16th, 2021

KalVista reports "positive" results from Phase 2 trial of KVD900

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 9th, 2021

Regeneron reports "positive" results from Phase 3 trial evaluating REGEN-COV

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 26th, 2021

DBV Technologies reports "positive" topline results from Phase III trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2020

Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update

 -- Reported Positive Topline Results from Pivotal Phase 3 URIROX-1 Trial.....»»

Category: earningsSource: benzingaNov 13th, 2019

miRagen Reports Third Quarter 2019 Results and Provides Corporate Update

Announced positive data from two Phase 1 clinical trials of MRG-110 Remain on track to announce interim top-line data from its Phase 2 clinical trial of remlarsen in keloids by year end Implemented restructuring to focus resour.....»»

Category: earningsSource: benzingaNov 7th, 2019

Krystal Biotech Reports Second Quarter 2019 Financial and Operating Results

FDA grants RMAT designation for KB103 to treat dystrophic epidermolysis bullosa (DEB) Announced positive results from Phase 2 trial ("GEM-2") of KB103 Submitted an IND application .....»»

Category: earningsSource: benzingaAug 5th, 2019

Biohaven reports "positive" results from Phase 3 rimegepant clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2019

Aclaris Therapeutics reports "positive" results from Phase 2 trial of ATI-502

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2019

Bristol-Myers Reports Positive Data in NSCLC Trial on Opdivo

Bristol-Myers Squibb Company (BMY) announced positive results from the phase III trial, CheckMate -0.....»»

Category: worldSource: nytApr 16th, 2018

Bristol-Myers reports "positive" results from Phase 3 CheckMate -078 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 13th, 2018

MediciNova reports "positive" results from Phase 2 trial of MN-001

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 13th, 2018

AbbVie Posts Positive Data on Elagolix for Uterine Fibroids

AbbVie (ABBV) reports positive top-line results from a phase III extension trial on its investigational candidate Elagolix for .....»»

Category: personnelSource: nytAug 23rd, 2018

ObsEva reports additional "positive" Phase 3 results of IMPLANT 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 3rd, 2018

Concert Pharmaceuticals reports "positive" CTP-543 results in Phase 2a trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

Alkermes reports positive results in trial of schizophrenia treatment that reduces weight gain

Alkermes Plc announced positive results Thursday for a trial of its ALKS 3832 treatment for schizophrenia. The Phase 3 tr.....»»

Category: topSource: marketwatchNov 29th, 2018

Humanigen reports publication of results from Phase 3 COVID-19 lenzilumab trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 5th, 2021

BioLine RX rockets on heavy volume after "strikingly positive" trial data on cancer treatment

Shares of BioLine RX Ltd. rocketed 60% toward a 2-year high in very active trading Tuesday, enough to pace all of the premarket gainers, after the biopharmaceutical company announced positive results from a Phase 3 trial of its treatment for multi.....»»

Category: topSource: marketwatchMay 4th, 2021

I-MAB reports positive Phase 2 results for olamkicept in ulcerative colitis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 26th, 2021